Literature DB >> 19798469

Central nervous system involvement in CD4+/CD56+ hematodermic neoplasm: a report of two cases.

Nóra Eros1, Márta Marschalkó, Katalin Balassa, Bernadett Hídvégi, József Szakonyi, Sándor Ilniczky, Katalin Borka, Attila Kovács, Gyula Bottlik, Judit Hársing, Judit Csomor, Agota Szepesi, András Matolcsy, Sarolta Kárpáti, Judit Demeter.   

Abstract

CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK-cell lymphoma, is an uncommon, aggressive non-Hodgkin's lymphoma with cutaneous, lymph node, and bone marrow involvement at presentation. The disease is characterized by early leukemic phase; however, central nervous system involvement is rarely reported. Herein we describe two cases of CD4+/CD56+ hematodermic neoplasm with meningeal manifestation. Microscopic analysis and flow cytometry of cerebrospinal fluid proved to be diagnostic; however, imaging studies were not informative. These observations call attention to the possibility of central nervous system involvement, which could be more common than expected previously. Authors recommend routine cerebrospinal fluid analysis and prophylactic intrathecal chemotherapy in patients with this highly aggressive disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798469     DOI: 10.1007/s11060-009-0026-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.

Authors:  Mirjana Urosevic; Curdin Conrad; Jivko Kamarashev; Kenji Asagoe; Antonio Cozzio; Günter Burg; Reinhard Dummer
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

2.  Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.

Authors:  Ashley P Ng; Stephen Lade; Timothy Rutherford; Christopher McCormack; H Miles Prince; David A Westerman
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

Review 3.  Cutaneous monomorphous CD4- and CD56-positive large-cell lymphoma.

Authors:  T Nagatani; H Okazawa; T Kambara; K Satoh; H Tokura; M Miyazawa; R Yamada; N Baba; H Nakajima; E Yamazaki; H Kanamori; H Mohri
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

4.  Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.

Authors:  David L Jaye; Cissy M Geigerman; Marco Herling; Karen Eastburn; Edmund K Waller; Dan Jones
Journal:  Mod Pathol       Date:  2006-09-22       Impact factor: 7.842

5.  Blastic natural killer cell lymphoma/leukemia: a report of seven cases.

Authors:  Michael G Bayerl; Christiane K Rakozy; Anwar N Mohamed; Trieu D Vo; Michael Long; David Eilender; Margarita Palutke
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

Review 6.  CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.

Authors:  N Kato; K Yasukawa; K Kimura; H Sugawara; S Aoyagi; T Mishina; T Nakata
Journal:  J Am Acad Dermatol       Date:  2001-02       Impact factor: 11.527

7.  CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC).

Authors:  T Petrella; S Dalac; M Maynadié; F Mugneret; E Thomine; P Courville; P Joly; B Lenormand; L Arnould; J Wechsler; M Bagot; C Rieux; J Bosq; M F Avril; A Bernheim; T Molina; A Devidas; M H Delfau-Larue; P Gaulard; D Lambert
Journal:  Am J Surg Pathol       Date:  1999-02       Impact factor: 6.394

8.  CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.

Authors:  M W Bekkenk; P M Jansen; C J L M Meijer; R Willemze
Journal:  Ann Oncol       Date:  2004-07       Impact factor: 32.976

Review 9.  A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.

Authors:  J Kameoka; R Ichinohasama; M Tanaka; I Miura; Y Tomiya; S Takahashi; M Yamada; I Ishikawa; I Kadowaki; O Sasaki; J Kimura; K Meguro; K Ooya; S Ito
Journal:  Am J Clin Pathol       Date:  1998-10       Impact factor: 2.493

10.  High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.

Authors:  M Adachi; K Maeda; M Takekawa; Y Hinoda; K Imai; S Sugiyama; A Yachi
Journal:  Am J Hematol       Date:  1994-12       Impact factor: 10.047

View more
  2 in total

1.  Nasal-Type Extranodal Natural Killer/T Cell Lymphoma with Meningeal Involvement: A Case Report and Literature Review.

Authors:  Chunli Yang; Hongyu Zhuo; Liqun Zou
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-30       Impact factor: 0.900

2.  Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement.

Authors:  Hayder Saeed; Mukta Awasthi; Abeer Al-Qaisi; Suleiman Massarweh
Journal:  Rare Tumors       Date:  2014-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.